For those interested in biotech penny stocks, today’s article highlights four to watch, two of which are up over 140% year-to-date. For these four biotech penny stocks – which include a clinical-stage immuno-oncology company focused on innovative treatments and a large producer of COVID-19 tests that, due to its role in helping to fight the pandemic, posted a revenue surge of roughly 33% in the second quarter alone – CLICK HERE.
![](https://www.hotstockanalyst.com/wp-content/uploads/2020/10/2020-10-04-19_18_26-Set-of-various-medical-equipment-for-successful-taking-of-vein-blood-·-Free-Stoc.png)